𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparative effectiveness research in inflammatory bowel disease

✍ Scribed by Eoin Slattery; Gavin C. Harewood


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
43 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Complementary and alternative medicine:
✍ Dr. Robert J. Hilsden; Marja J. Verhoef πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 538 KB

The use of complementary and alternative medicine (CAM) by patients with inflammatory bowel disease (IBD) is common. Physicians and scientists believe that the randomized controlled trial (RCT) provides the best evidence of an intervention's efficacy. However, thcre are only a few controlled trials

Lymphoma in inflammatory bowel disease
✍ Adrian J. Greenstein; Gerard E. Mullin; James A. Strauchen; Tomas Heimann; Henry πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 481 KB πŸ‘ 1 views
MicroRNAs in inflammatory bowel disease
✍ Joel R. Pekow; John H. Kwon πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 1 views

MicroRNAs (miRNAs) are small, noncoding RNAs that regulate gene and protein expression. miRNAs are critical to a normal immune response and have altered expression in multiple immune-mediated disorders. This emerging role of miRNAs in the pathogenesis of multiple disease states has led to investigat

Pyoderma gangrenosum in inflammatory bow
✍ M. D. Levitt; J. K. Ritchie; J. E. Lennard-Jones; Mr. R. K. S. Phillips πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 293 KB πŸ‘ 2 views
Mucocutaneous manifestations in inflamma
✍ Δ°lhami YΓΌksel; Γ–mer Başar; Hilmi Ataseven; Δ°brahim Ertuğrul; Mehmet Arhan; Mehme πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 2 views

## Background: The aim of this study was to evaluate the prevalence and features of the major cutaneous manifestations (erythema nodosum [en] and pyoderma gangrenosum [pg]) and to determine the associations between cutaneous manifestations and other extraintestinal manifestations in patients with i